(Q51323736)

3 April 2018

title

Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3. (English)

1 reference

3 April 2018

main subject

hepatocellular carcinoma

1 reference

Jiajie Hou

1

1 reference

3 April 2018

Juan Xu

2

1 reference

3 April 2018

Runqiu Jiang

3

1 reference

3 April 2018

Youjing Wang

4

1 reference

3 April 2018

Chen Chen

5

1 reference

3 April 2018

Lei Deng

6

1 reference

3 April 2018

Xingxu Huang

7

1 reference

3 April 2018

Xuehao Wang

8

1 reference

3 April 2018

Beicheng Sun

9

1 reference

3 April 2018

language of work or name

English

0 references

publication date

30 October 2012

1 reference

3 April 2018

published in

Hepatology

1 reference

3 April 2018

volume

57

1 reference

3 April 2018

issue

2

1 reference

3 April 2018

page(s)

678-688

1 reference

3 April 2018

Protein tyrosine phosphatases in the human genome

cites work

1 reference

Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy

21 January 2018

1 reference

Functional involvement of PTP-U2L in apoptosis subsequent to terminal differentiation of monoblastoid leukemia cells

21 January 2018

1 reference

Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia

21 January 2018

1 reference

Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas

21 January 2018

1 reference

Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer

21 January 2018

1 reference

Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity

21 January 2018

1 reference

Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma

21 January 2018

1 reference

Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study

21 January 2018

1 reference

Environmental factors and risk for hepatocellular carcinoma

21 January 2018

1 reference

Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C

21 January 2018

1 reference

Upstream regions of the estrogen receptor alpha proximal promoter transcript regulate ER protein expression through a translational mechanism.

21 January 2018

1 reference

Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.

21 January 2018

1 reference

Integration of the extranuclear and nuclear actions of estrogen

21 January 2018

1 reference

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

21 January 2018

1 reference

Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

21 January 2018

1 reference

Opposite regulation of myc and p21waf1 transcription by STAT3 proteins

21 January 2018

1 reference

Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells

21 January 2018

1 reference

Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor

21 January 2018

1 reference

Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification.

21 January 2018

1 reference

Induction of epithelial tubules by growth factor HGF depends on the STAT pathway

21 January 2018

1 reference

Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR

21 January 2018

1 reference

Janus kinases: components of multiple signaling pathways

21 January 2018

1 reference

Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis

21 January 2018

1 reference

Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors

21 January 2018

1 reference

The role of signaling pathways in the development and treatment of hepatocellular carcinoma

21 January 2018

1 reference

Activation of PI3K/AKT and MAPK pathway through a PDGFRβ-dependent feedback loop is involved in rapamycin resistance in hepatocellular carcinoma

21 January 2018

1 reference

Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling

21 January 2018

1 reference

CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling

21 January 2018

1 reference

PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis

21 January 2018

1 reference

miR-22 promotes HBV-related hepatocellular carcinoma development in males

21 January 2018

1 reference

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

21 January 2018

1 reference

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

21 January 2018

1 reference

A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling

21 January 2018

1 reference

Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer

21 January 2018

1 reference

Gene expression profiles in breast cancer to identify estrogen receptor target genes.

21 January 2018

1 reference

Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation

21 January 2018

1 reference

Src kinase regulation by phosphorylation and dephosphorylation

21 January 2018

1 reference

Redox redux: revisiting PTPs and the control of cell signaling

21 January 2018

1 reference

Estrogen Receptor Classification for Hepatocellular Carcinoma: Comparison With Clinical Staging Systems

21 January 2018

1 reference

Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.25980

1 reference

3 April 2018

1 reference

3 April 2018